J.R.W. UTILITY PUBLIC COMPANY LIMITEDSET: JR🇹🇭 TH

Internal Control · 2025

Internal Control — Board Opinion

Summary of the Board's Opinion on Internal Control

-

Adequacy & Appropriateness of the Internal Control System

Internal Control Framework Used

FrameworkDetail
The Committee of Sponsoring Organizations of the Treadway Commission (COSO)

The Board of Directors has reviewed and acknowledged the results of the Company's internal control audit, as submitted by P&L Internal Audit Co., Ltd., as per Attachment No. 9 of the Board of Directors meeting. The Audit Committee summarized the 2025 operating results, with the following key points:

Based on an assessment of the Company's and its subsidiaries' internal control systems across five components:

  1. Control Environment

  1. Risk Assessment

  1. Control Activities

  1. Information & Communication System

  1. Monitoring Activities

The Board concludes that the Company's internal control systems are adequate and appropriate. The Company have sufficient personnel to effectively implement the systems. Furthermore, the Company has internal controls in place to monitor and oversee the operations of company, adequately protecting company assets from misuse or unauthorized use by directors or executives, including transactions with potentially conflicting interests and related parties. The Company adheres to the internal control principles as outlined in the assessment, with supporting documentation for every aspect. The Company has also reviewed its key policies to ensure appropriate operational practices. The previous internal audit covered the Company's critical operational processes. And clear measures for improvement and correction have been established.

Internal Control Deficiencies

Number of Deficiencies

MetricCurrent YearPrevious YearTwo Years Ago
Total number of internal control system deficiencies (cases)000

Audit Committee & Auditor Observations

Audit Committee's Opinion Differs from the Board's

Yes

Audit Committee's Differing Opinion

P&L Corporation Limited conducted an internal audit for the year 2568 (2025) according to the following work plan: Expenditure Cycle, Revenue Cycle, Payroll Management, General IT Controls - General Controls. The audit results were presented and discussed with the Audit Committee every quarter. Based on the audit of the company's systems, the company has appropriate operations. There were some issues that the auditors recommended to the company for improvement, and the company has implemented them accordingly.

Auditor Has Observations on Internal Control

No

Opinion on the Head of Internal Audit

Head of Internal Audit

3160

Audit Committee's Opinion on the Head of Internal Audit

The company has contracted an external agency, P&L Corporation Co., Ltd., and assigned Ms. Wanwimon Jongsureepas to serve as the Head of Internal Audit for the year 2025. The Audit Committee meeting No. 1/2025, held on February 26, 2025, approved this appointment. The Audit Committee believes that Ms. Wanwimon Jongsureepas is well-suited to perform the duties of the Head of Internal Audit effectively, given her educational qualifications, experience, and relevant training. These qualifications are in line with the requirements for the position of Head of Internal Audit.

Appointment, Discharge & Transfer of the Head of Internal Audit

Requires Audit Committee Approval

Yes

Description

The consideration and approval of the appointment, removal, or transfer of the Head of Internal Audit must be approved (or acknowledged) by the Audit Committee. The qualifications of the Head of Internal Audit are shown in Appendix 3.

Related Party Transactions

Has Related Party Transactions

Yes

Counterparties & Transactions

Monetary Unit

1000000

Counterparties with Potential Conflicts

NamePerson / Juristic PersonType of BusinessNature of RelationshipAs of Date (YYYY-MM-DD)
Sikarin Hospital (Operated by Sikarin Public Company Limited)Juristic PersonPrivate Hospital Business

There is a common director, Mr. Jaran Viwatjesadawut, holding 24,417,319 shares, representing 1.19 percent of the total number of issued and outstanding shares of Synchrotron Public Company Limited as of September 30, 2025.

2025-09-30T00:00
Jarun WiwatjesadawutPerson

Holds the position of authorized signatory director and Chief Executive Officer. He is a shareholder of the company, holding 268,609,218 shares, representing 35.33% of the total issued shares of the company (including related parties) as of December 31, 2025.

2025-12-31T00:00

Transactions by Counterparty

Transactions
0.2 · Necessity: Comparisons were made with the prices of two other service providers offering similar services. Sikarin Hospital offers general market prices. · Description: The Company hired Sikarin Hospital to conduct annual employee health check-ups, which is a common practice in the industry. The price was compared to two other service providers offering similar services. Sikarin Hospital offered a general market price. · As of yesteryear: 0.25 · Nature of transaction: Sikarin Hospital's Annual Employee Health Check-up · Audit committee opinion: The Audit Committee has reviewed and is of the opinion that the aforementioned services are beneficial to the company. These services are in line with general commercial practices, and the pricing is consistent with market rates. · As of year before yesteryear: 0.19

Policy & Future Trends

Policy, Measures & Approval Process

The Company has established measures for transactions between the Company and related parties. The Audit Committee will provide opinions on the necessity, reasonableness, and appropriateness of the transaction price. This will be considered based on various conditions to ensure that it aligns with normal business practices at market prices, comparable to prices offered to external parties. In cases where the Audit Committee lacks expertise in considering potential related party transactions, the Company will engage independent experts, such as auditors, property appraisers, or law firms, who are independent from the Company and related parties, to provide opinions on such transactions. These opinions will be used to support the Audit Committee's decision-making process before presenting it to the Board of Directors or shareholders, as appropriate. Furthermore, the Company has implemented measures to prevent directors or interested parties from participating in the approval of transactions in which they have a direct or indirect interest. The Board of Directors is responsible for ensuring the Company's compliance with the Securities and Exchange Act, regulations, notifications, orders, or requirements of the Securities and Exchange Commission and the Stock Exchange of Thailand. This includes compliance with disclosure requirements for related party transactions, the acquisition or disposal of significant assets of the Company or its subsidiaries, and adherence to accounting standards set by the Federation of Accounting Professions and the Certified Public Accountants of Thailand. The Company will disclose related party transactions in the notes to the financial statements audited or reviewed by the Company's auditors.

Future Trends in Related Party Transactions

The Company may continue to have related party transactions in the future, which will be in accordance with the nature of general trading business. The Company will establish a clear policy on related party transactions, with prices and trading conditions that are in line with normal business practices, as well as those stipulated for unrelated persons and/or companies. These transactions may include the purchase of goods, provision or receipt of various services, and guarantees for credit facilities of the Company's directors. Related party transactions that may occur will be necessary for the Company's business operations and in the best interests of the Company. In addition, the Company has a policy prohibiting directors, executives, and employees from borrowing from the Company. The Audit Committee will review compliance with the regulations and provide opinions on the reasonableness of the transactions that occur every quarter. Currently, the Company is in the process of negotiating with commercial banks to release the guarantees for credit facilities of the Company's directors and shareholders.

Contents